On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

RNASEH2A

ribonuclease H2 subunit A

The RNASEH2A gene provides instructions for a component of the RNase H2 complex, an enzyme crucial for processing RNA-DNA hybrids and maintaining genomic stability. RNASEH2A encodes subunit A of the ribonuclease H2 complex, an enzyme that plays a vital role in cellular processes by breaking down RNA-DNA hybrid molecules.

Chromosome 19p13.13 Various HGNC:18518 Tier C
RNASEH2A 19p13.13 p arm q arm 19

RNASEH2A is located on the short (p) arm of chromosome 19, at band 19p13.13. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 19 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The RNASEH2A gene is responsible for producing one of the subunits of the RNase H2 complex, a crucial enzyme found within human cells. This complex is a type of ribonuclease, which means it facilitates the breakdown of RNA-containing molecules. Specifically, it targets RNA-DNA hybrids, which are structures composed of one strand of RNA bound to one strand of DNA.

These RNA-DNA hybrids are formed naturally during the process of DNA replication in all cells. Proper functioning of the RNase H2 complex, and thus the RNASEH2A gene, is essential for maintaining genomic integrity and is implicated in various cellular functions, including immune response regulation.

What the gene does

The RNASEH2A gene directs the synthesis of subunit A of the RNase H2 complex, an enzyme with vital roles in nucleic acid metabolism. The primary function of the RNase H2 complex is its ribonuclease activity, specifically targeting and degrading RNA-DNA hybrid molecules. These hybrids naturally arise during DNA replication as part of the cellular machinery.

Beyond its role in RNA-DNA hybrid processing, the RNase H2 complex is also thought to contribute to DNA replication accuracy and the repair of errors in the DNA sequence. This complex additionally plays a part in the immune system, where it helps to remove unnecessary DNA fragments that could otherwise trigger an inappropriate immune response.

Video: Genetics 101

Chromosome location

The RNASEH2A gene is situated on chromosome 19. Its precise location is on the short arm of chromosome 19, at position 13.13, which is designated as 19p13.13. This specific genomic address helps to locate the gene within the vast human genome.

Protein structure

The RNASEH2A protein is composed of 299 amino acids. A key structural feature of the RNASEH2A protein is the RNase H type-2 domain, which spans amino acids 28 to 250. This domain is integral to the protein's enzymatic activity within the RNase H2 complex.

Domain map · 299 amino acids
RNase H type-2 (28-250)RNase H type-228-2501~150299
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:O75792Length:299 aaStructure:AlphaFold

Key variants

Genetic variations, or variants, within the RNASEH2A gene can alter the protein's structure and function. These changes can lead to a dysfunctional RNase H2 complex, impairing its ability to properly process RNA-DNA hybrids and perform its other cellular roles. The clinical impact of RNASEH2A variants can vary depending on the specific change.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for RNASEH2A.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.206dup
Duplication
p.Thr70fs Pathogenic/Likely pathogenic ★★☆☆ RNASEH2A-related disorder
c.229del
Deletion
p.Glu77fs Pathogenic/Likely pathogenic ★★☆☆ Aicardi-Goutieres syndrome 4
c.447C>A
single nucleotide variant
p.Tyr149Ter Pathogenic/Likely pathogenic ★★☆☆ Aicardi-Goutieres syndrome 4
c.543_544del
Microsatellite
p.Ala182fs Pathogenic/Likely pathogenic ★★☆☆ Aicardi-Goutieres syndrome 4
c.556C>T
single nucleotide variant
p.Arg186Trp Pathogenic/Likely pathogenic ★★☆☆ Aicardi Goutieres syndrome
c.557G>A
single nucleotide variant
p.Arg186Gln Pathogenic/Likely pathogenic ★★☆☆ RNASEH2A-related disorder
c.589del
Deletion
p.Glu197fs Pathogenic ★★☆☆ RNASEH2A-related disorder
c.657G>A
single nucleotide variant
p.Trp219Ter Pathogenic/Likely pathogenic ★★☆☆ Aicardi-Goutieres syndrome 4
c.205_208del
Deletion
p.Lys69fs Pathogenic ★☆☆☆ Aicardi-Goutieres syndrome 4
c.238_241del
Deletion
p.Phe80fs Pathogenic ★☆☆☆ Aicardi-Goutieres syndrome 4

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the RNASEH2A gene are associated with certain inherited conditions. Notably, pathogenic variants in RNASEH2A have been identified in individuals diagnosed with Aicardi-Goutières syndrome. This condition often presents with severe brain dysfunction, characteristic skin lesions, and other health complications.

UK clinical status

The RNASEH2A gene is included in several expert-curated panels within the UK's NHS Genomic Medicine Service via PanelApp. It is rated 'green' for multiple panels, indicating strong evidence for its gene-disease association. These panels include 'COVID-19 research', 'DDG2P', 'Early onset or syndromic epilepsy', 'Foetal anomalies', 'Inherited white matter disorders', 'Intellectual disability', 'Intracerebral calcification disorders', 'Leukodystrophy, adult onset', 'Likely inborn error of metabolism', 'Primary immunodeficiency or monogenic inflammatory bowel disease', and 'White matter disorders and cerebral calcification - childhood onset'.

Frequently asked questions

What is the primary function of the RNASEH2A gene?

The RNASEH2A gene provides instructions for making one part of the RNase H2 complex. This enzyme complex is primarily responsible for breaking down RNA-DNA hybrid molecules, which are formed during DNA replication.

What health condition is associated with RNASEH2A variants?

Variants in the RNASEH2A gene are associated with Aicardi-Goutières syndrome. This is a severe disorder that affects brain function, skin, and can cause other health problems.

How does the RNase H2 complex contribute to immune function?

Beyond its role in DNA processing, the RNase H2 complex is thought to be involved in the immune system. It helps to remove extraneous DNA pieces that could otherwise trigger an inappropriate immune response.

References

  1. Feng S, Cao Z. Is the role of human RNase H2 restricted to its enzyme activity? Progress in biophysics and molecular biology. 2016. PMID: 26603688
  2. Livingston JH, Crow YJ. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond. Neuropediatrics. 2016. PMID: 27643693
  3. Crow YJ, Chase DS, Lowenstein Schmidt J. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. American journal of medical genetics. Part A. 2015. PMID: 25604658
  4. Cuadrado E, Michailidou I, van Bodegraven EJ. Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release. Journal of immunology (Baltimore, Md. : 1950). 2015. PMID: 25769924
  5. Rice GI, Forte GM, Szynkiewicz M. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. The Lancet. Neurology. 2013. PMID: 24183309
  6. Perrino FW, Harvey S, Shaban NM. RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases. Journal of molecular medicine (Berlin, Germany). 2009. PMID: 19034401
  7. Rice G, Patrick T, Parmar R. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. American journal of human genetics. 2007. PMID: 17846997
  8. Adam MP, Bick S, Mirzaa GM. Aicardi-Goutières Syndrome. 1993. PMID: 20301648
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .